Skip to content
Kalpvruksh Markets
Offline Log in

NEULANDLABNSEOffline

NEULAND LABORATORIES · INE794A01010 · Small Cap · #366
19,783.00+207.00 (+1.06%)last close · 05 Nov 2026
Prev close
19,576.00
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹18,898 cr
52-week range · to 05 Nov 202611,55523,995

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

NEULANDLAB is 18% below its 52-week high, above its 200-day average, behind Healthcare by 1.8 pts over 3 months — a Small Cap company, #366 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

F&O · next review 2026-11-16 · our estimateWill NEULANDLAB get futures & options?
Strong candidate NEULANDLAB has met every criterion we can compute at 2 of the last 3 monthly reviews. NSE also applies an order-size test that is not public, and SEBI approves a few stocks a month.Rank (cap · value): #314 · #273 · Delivery / day: ₹47 crOur estimate, not the exchange’s or the index provider’s. Not advice.

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 200-day averages · below its 50-day average · 18% below its 52-week high
  • behind its industry by 1.8 pts over 3 months · rank 27 of 44 in Healthcare · +1.3% vs Nifty 500
  • traded value 1.4× usual · delivery 48% vs 47% usual
  • FPI +0.9 pp · DII −0.3 pp · MF schemes in Sept 2026: 31 bought, 40 cut · promoter pledge 2.3% · insiders net bought ₹0 cr in 3 months · quarter ended 2026-09-30
  • Jun 2026 quarter: profit +962% year on year · revenue +119%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹18,898 cr
Rank
#366
Cap band
Small Cap
Nearest cut-off — Mid / Small
−44.73% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.3×
median 27,070
Delivered
35,334
Of volume
51%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+2.6%−3.1 pts—
1 month−9.7%−13.7 pts−13.1 pts
3 months−0.9%+1.3 pts−1.8 pts
6 months+16.2%+15.7 pts+4.7 pts
1 year+22.4%+25.7 pts—

Industry: Healthcare (Nifty 500 classification) · rank 27 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+0.3%
above
vs 50-day average
−7.8%
below
vs 200-day average
+13.0%
above
ATR (14)
4.0%
typical daily range
Volatility
26%
1 month, annualised
Beta
0.98
vs Nifty 500, 1 year
Traded value
1.4×
vs usual
Delivery
48%
usual 47%
From the 52-week high
−17.6%
place in range 66% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters32.6%32.6%32.6%32.3% −0.4
FPI20.9%20.5% −0.421.1% +0.621.9% +0.9
Mutual funds10.4%11.3% +1.012.7% +1.312.4% −0.2
Other DII4.3%4.5% +0.23.9% −0.63.8% −0.1
Individuals24.3%23.9% −0.522.9% −1.022.5% −0.4
Others7.4%7.2% −0.26.9% −0.37.1% +0.2

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
2.3%
Of all shares
0.75%
Jun 25 noneSep 25 noneDec 25 noneMar 26 2.3%Jun 26 2.3%Sep 26 2.3%

Holders

Sep 26

All shareholders
49,741
Individuals
45,850

Indian passive funds’ stake

2026-06-30

Of free float
0.91%
Of all shares
0.61%
Schemes
56
Days to unwind
1.4
at 100% of volume

78,829 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
123
56 index · 67 active
Bought more
59
Sold some
22
FundSharesChangeDid
Mahindra Manulife Multi Cap Fund-Reg(G)Active+47,301+64.1%bought
HDFC Pharma and Healthcare Fund-Reg(G)Active+15,900+62.8%bought
Mirae Asset Small Cap Fund-Reg(G)Active+14,737+38.0%bought
Tata India Pharma & Healthcare Fund-Reg(G)Active−8,716−41.0%sold
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETFIndex−2,734−25.7%sold
Mahindra Manulife Flexi Cap Fund-Reg(G)Active−2,200−19.6%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 26105922355−1.9%₹2,626 cr
Aug 26101942155−1.3%₹2,885 cr
Jul 2697538198+4.7%₹2,419 cr
Jun 26100834174+0.9%₹2,255 cr
May 2696630214+3.8%₹2,056 cr
Apr 269484286+0.7%₹1,740 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
Bought ₹0 (1)
Sold ₹0 (1)
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 16 of 17 disclosures
0 selected
28 Sept 2026Davuluri Rohini Niveditha RaoPromoter GroupSell10,000₹00.00%Gift
28 Sept 2026Davuluri Saharsh RaoPromoter and DirectorBuy10,000₹00.02%Gift
25 Mar 2026Davuluri Saharsh RaoPromotersPledge96,000₹116 cr1.52%Pledge Creation
04 Mar 2026Deepthi DavuluriPromoter GroupBuy12,500₹00.01%Gift
04 Mar 2026Davuluri Saharsh RaoPromotersSell12,500₹01.52%Gift
17 Dec 2025Ms. Kamala Tayaramma KommulaPromoter GroupBuy6,000₹00.01%—
17 Dec 2025Mr. Gannabathula Venkata Krishna Rama RaoPromotersSell6,000₹00.01%Gift
23 Sept 2025Ms. Gannabathula Venkata Vani SriranganayakammaPromoter GroupBuy9,000₹00.01%Gift
23 Sept 2025Mr.Gannabathula Veeravenkata SatyanarayanamurtyPromoter GroupBuy10,000₹00.24%Gift
23 Sept 2025Mr. Gannabathula Venkata Krishna Rama RaoPromotersSell19,000₹00.01%Gift
28 Feb 2025Davuluri Ownership TrustPromotersBuy79,462₹025.98%Gift
28 Feb 2025Saharsh Rao DavuluriPromotersSell79,462₹01.62%Gift
25 Feb 2025Davuluri Ownership TrustPromotersBuy32,53,890₹025.36%Gift
25 Feb 2025Sucheth Rao DavuluriPromotersSell79,573₹02.01%Gift
24 Feb 2025Davuluri Ramamohan RaoPromotersSell25,65,979₹01.63%Gift

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Neuland Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    03 Nov 2026
  • Credit rating
    Neuland Laboratories Limited has informed the Exchange about Credit Rating
    26 Aug 2026
  • Board outcome
    Neuland Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    05 Aug 2026
  • Credit rating
    Neuland Laboratories Limited has informed the Exchange about Credit Rating
    14 Jul 2026
  • Bulk deal: BUY
    64,547 at ₹21,585 — HDFC MUTUAL FUND
    06 Aug 2026

NEULANDLAB: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹34Final24 Jul 202624 Jul 2026
EarlierDividend₹12Final18 Jul 202518 Jul 2025
EarlierDividend₹14Final12 Jul 202413 Jul 2024
EarlierDividend₹10Final11 Jul 202312 Jul 2023
EarlierDividend₹5Final14 Jul 202215 Jul 2022
EarlierRights4:25—13 Aug 201414 Aug 2014at ₹204
EarlierRights5:12—21 Mar 201223 Mar 2012at ₹45

7 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.